<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">AMINOPHYLLINE (theophylline ethylenediamide)</span><br/>(am-in-off'i-lin)<br/><span class="topboxtradename">Corophyllin <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename"> Paladron <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Phyllocontin, </span><span class="topboxtradename">Somophyllin, </span><span class="topboxtradename">Somophyllin-DF, </span><span class="topboxtradename">Truphylline<br/></span><b>Classifications:</b> <span class="classification">bronchodilator (respiratory smooth muscle relaxant)</span>; <span class="classification">xanthine</span><br/><b>Prototype: </b>Theophylline<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg, 200 mg tablets; 225 mg sustained release tablets; 105 mg/5 mL oral liquid; 250 mg/10 mL injection; 250 mg, 500 mg suppositories</p>
<h1><a name="action">Actions</a></h1>
<p>Aminophylline is a salt of theophylline with effects similar to those of other xanthines (e.g., caffeine and theobromine).
         Action is dependent on theophylline content (approximately 80%) and is measured as theophylline in the serum.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It is a respiratory smooth muscle relaxant that results in bronchodilation.</p>
<h1><a name="uses">Uses</a></h1>
<p>To prevent and relieve symptoms of acute bronchial asthma and treatment of bronchospasm associated with chronic bronchitis
         and emphysema.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>As a respiratory stimulant in Cheyne-Stokes respiration; for treatment of apnea and bradycardia in premature infants; as cardiac
         stimulant and diuretic in treatment of CHF.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to xanthine derivatives or to ethylenediamine component; cardiac arrhythmias. Safety during pregnancy (category
         C) or lactation is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Severe hypertension, cardiac disease, arrhythmias; impaired hepatic function; diabetes mellitus; hyperthyroidism; glaucoma;
         prostatic hypertrophy; fibrocystic breast disease; history of peptic ulcer; neonates and young children, patients over 55
         y; COPD, acute influenza or patients receiving influenza immunization.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Bronchospasm</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV Loading Dose</span> 6 mg/kg over 30 min <span class="rdroute">IV Maintenance Dose</span>
<i>nonsmoker</i>, 0.5 mg/kg/h; <i>smoker</i>, 0.75 mg/kg/h; <i>CHF or cirrhosis</i>, 0.25 mg/kg/h <span class="rdroute">PO</span>
<i>nonsmoker,</i> 0.5 mg/kg/h times 24 h in 4 divided doses; <i>smoker,</i> 0.75 mg/kg/h times 24 h in 4 divided doses; <i>CHF or cirrhosis,</i> 0.25 mg/kg/h times 24 h in 4 divided doses<br/><span class="rdage">Child:</span> <span class="rdroute">IV Loading Dose</span> 6 mg/kg IV over 30 min <span class="rdroute">IV Maintenance Dose</span>
<i>19 y</i>, 1 mg/kg/h; <i>&gt;9 y,</i> 0.75 mg/kg/h <span class="rdroute">PO</span>
<i>19 y,</i> 1 mg/kg/h times 24 h in 4 divided doses; <i>&gt;9 y,</i> 0.75 mg/kg/h times 24 h in 4 divided doses<br/><span class="rdage">Infant:</span> <span class="rdroute">PO/IV</span>
<i>611 mo,</i> 0.87 g/kg/h; <i>26 mo,</i> 0.5 mg/kg/h<br/><span class="rdage">Neonate:</span> <span class="rdroute">PO/IV</span> 0.16 mg/kg/h<br/><br/><span class="indicationtitle">Neonatal Apnea</span><br/><span class="rdage">Neonate:</span> <span class="rdroute">PO/IV Loading Dose</span> 5 mg/kg <span class="rdroute">PO/IV Maintenance Dose</span> 5 mg/kg/d divided q12h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<ul>
<li>
            				Note: All doses based on ideal body weight.
            			
         </li>
</ul><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with a full glass of water on an empty stomach (½1 h before or 2 h after meals) for faster absorption, which is
            delayed but is not reduced with food.
         </li>
<li>Minimize GI symptoms by taking immediately after a meal or with food.</li>
<li>Do not chew or crush extended (controlled) release preparations before swallowing; however, if tablet is scored, it can be
            broken in half, then swallowed.
         </li>
<li>Do mix contents of extended release capsules with soft, moist food to promote swallowing.</li>
</ul><span class="adminroutetype">Suppository</span><br/><ul>
<li>
            				Note: Rectal preparations may be ordered when patient must fast or cannot tolerate the drug orally; absorption is enhanced if rectum
            is empty.
            			
         </li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><ul>
<li>Verify correct IV concentration and rate of infusion with physician for neonates, infants, and children.</li>
</ul>
<p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span>  Dilute loading dose in 100200 mL NS, D5W, D5/NS, or RL. For continuous or intermittent infusion dilute in 5001000
                  mL. Do not use aminophylline solutions if discolored or if crystals are present. 
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">IV Infusion:</span> Infuse at a rate not to exceed 25 mg/min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span>
<b>amikacin,</b>
<b>bleomycin,</b>
<span class="classification">cephalosporins</span>, <b>chlorpromazine,</b>
<b>ciprofloxacin,</b>
<b>clindamycin,</b>
<b>codeine phosphate,</b>
<b>dimenhydrinate,</b>
<b>dobutamine,</b>
<b>dopamine,</b>
<b>doxapram,</b>
<b>doxorubicin,</b>
<b>epinephrine,</b>
<b>hydralazine,</b>
<b>hydroxyzine,</b>
<b>insulin,</b>
<b>isoproterenol,</b>
<b>levor phanol,</b>
<b>meperidine,</b>
<b>methadone,</b>
<b>methylprednisolone,</b>
<b>morphine,</b>
<b>nafcillin,</b>
<b>norepinephrine,</b>
<b>oxytetracycline,</b>
<b>papaverine,</b>
<b>penicillin G,</b>
<b>pentazocine,</b>
<b>procaine,</b>
<b>prochlorperazine,</b>
<b>promazine,</b>
<b>promethazine,</b>
<b>tetracycline,</b>
<b>verapamil,</b>
<b>vitamin B complex with C</b>. <span class="incompattype">Y-site:</span>
<b>amiodarone,</b>
<b>codeine phosphate,</b>
<b>ciprofloxacin,</b>
<b>clindamycin,</b>
<span class="classification">phenothiazines</span> (<b>chlorpromazine,</b>
<b>prochlorperazine,</b> etc.), <b>epinephrine,</b>
<b>dobutamine,</b>
<b>dopamine,</b>
<b>levorphanol,</b>
<b>morphine,</b>
<b>meperidine,</b>
<b>methadone,</b>
<b>norepi- nephrine,</b>
<b>verapamil.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Store at 15°30° C (59°86° F) in tightly closed containers unless otherwise directed.</li>
<li>Follow manufacturer's directions regarding storage of suppositories; some can be stored at room temperature; others must be
            refrigerated.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span>
<span class="speceff-common">Nervousness</span>, restlessness, depression, insomnia, irritability, headache, dizziness, muscle hyperactivity, convulsions. <span class="typehead">CV:</span> Cardiac arrhythmias, tachycardia (with rapid IV), hyperventilation, chest pain, <span class="speceff-life">severe hypotension, cardiac arrest</span>. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea, vomiting, anorexia</span>, hematemesis, diarrhea, epigastric pain. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Increases <b>lithium</b> excretion, lowering <b>lithium</b> levels; <b>cimetidine,</b> high-dose <b>allopurinol</b> (600 mg/d), <b>ciprofloxacin,</b>
<b>erythromycin,</b>
<b>troleandomycin</b> can significantly increase <b>theophylline</b> levels. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Most products are 100% absorbed from GI tract. <span class="typehead">Peak:</span> IV 30 min; uncoated tablet 1 h; sustained release 46 h. <span class="typehead"> Duration:</span>  48 h; varies with age, smoking, and liver function. <span class="typehead">Distribution:</span> Crosses placenta. <span class="typehead"> Metabolism:</span>  Extensively metabolized in liver. <span class="typehead">Elimination:</span> Parent drug and metabolites excreted by kidneys; excreted in breast milk. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of toxicity (generally related to theophylline serum levels over 20 mg/mL). Observe patients receiving parenteral
            drug closely for signs of hypotension, arrhythmias, and convulsions until serum theophylline stabilizes within the therapeutic
            range.
         </li>
<li>
            							Note: High incidence of toxicity is associated with rectal suppository use due to erratic rate of absorption.
            						
         </li>
<li>Monitor &amp; record vital signs and I&amp;O. A sudden, sharp, unexplained rise in heart rate may indicate toxicity.</li>
<li>Lab tests: Monitor serum theophylline levels.</li>
<li>
            							Note: Older adults, acutely ill, and patients with severe respiratory problems, liver dysfunction, or pulmonary edema are at greater
            risk of toxicity due to reduced drug clearance.
            						
         </li>
<li>
            							Note: Children appear more susceptible to CNS stimulating effects of xanthines (nervousness, restlessness, insomnia, hyperactive
            reflexes, twitching, convulsions). Dosage reduction may be indicated.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>
            							Note: Use of tobacco tends to increase elimination of this drug (shortens half-life), necessitating higher dosage or shorter intervals
            than in nonsmokers.
            						
         </li>
<li>Report excessive nervousness or insomnia. Dosage reduction may be indicated.</li>
<li>
            							Note: Dizziness is a relatively common side effect, particularly in older adults; take necessary safety precautions.
            						
         </li>
<li>Do not take OTC remedies for treatment of asthma or cough unless approved by physician.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>